How to Apply Nasal Spray in Both Nostrils in an Infant
For infants requiring nasal spray administration, position the child upright, hold the spray bottle upright, gently insert the nozzle tip into one nostril without forcing it deep, administer the prescribed number of sprays (typically 1 spray per nostril for most medications approved for ages 2-5 years), and repeat in the other nostril. 1
Age-Specific Dosing Considerations
The term "infant" typically refers to children under 1 year of age, but most nasal sprays have limited FDA approval for this age group:
- Intranasal steroids: The youngest FDA-approved age is ≥2 years for medications like triamcinolone acetonide (Nasacort), mometasone furoate (Nasonex), and fluticasone furoate (Veramyst) 1
- For children ages 2-5 years, the typical dose is 1 spray per nostril once daily 1
- For children ages 6-11 years, dosing increases to 2 sprays per nostril daily 1
Proper Administration Technique
Positioning
- Keep both the child and the spray bottle upright during administration 2
- This upright positioning is critical to avoid excessive medication delivery and potential systemic absorption 2
Step-by-Step Application
- Clear the nasal passages first if needed (using saline irrigation or gentle aspiration) 3, 4
- Gently insert the spray tip into the nostril—the tip should be adapted to fit infant nostrils comfortably 3
- Administer the prescribed number of sprays per nostril
- Avoid inserting the nozzle too deeply into the nasal cavity
- Repeat in the opposite nostril
Communication and Monitoring
- In any medical setting, carefully monitor the quantity of medication used 2
- The spray bottle design provides optimal lavage when used correctly in the upright position 3
Critical Safety Considerations
Decongestant Warnings
Oral and topical decongestants should be used with extreme caution or avoided entirely in infants and young children, as use in this population has been associated with serious adverse events including agitated psychosis, ataxia, hallucinations, and even death 5.
For topical nasal decongestants like oxymetazoline:
- FDA approval is only for children ≥6 years of age 2
- Off-label use in younger children may be considered only in specific urgent clinical scenarios where benefit clearly outweighs risk (active bleeding, acute respiratory distress) 2
- Exercise extreme caution with both dosing quantity and administration technique due to lack of adequate pediatric pharmacokinetic studies 2
Antihistamine Nasal Sprays
Intranasal antihistamines like azelastine are approved only for children ≥12 years of age at a dose of 2 sprays per nostril twice daily 5
Practical Considerations
Ease of Administration
Studies in children ages 2-5 years found that 67-91% of parents reported nasal spray administration as either "extremely easy" or "very easy" 6, suggesting that with proper technique and age-appropriate products, nasal spray delivery is feasible in young children.
Adjunctive Measures
Before applying medicated nasal sprays, consider:
- Saline irrigation to clear mucus and allow better medication contact with nasal mucosa 3, 4
- This improves medication effectiveness and accelerates recovery 3
- Isotonic saline solutions are safe and well-tolerated in infants 4
Common Pitfalls to Avoid
- Using the spray bottle at an angle or with the child lying down—this can lead to excessive medication delivery 2
- Administering medications not FDA-approved for the child's age—most nasal sprays are not approved for infants under 2 years
- Inserting the nozzle too deeply—this can cause discomfort and improper medication delivery
- Failing to clear nasal secretions first—medication is less effective when applied over thick mucus 3
- Using decongestants in young children—associated with serious adverse events 5